GRDN · Guardian Pharmacy Services, Inc. · Executive Compensation
$40.78
+0.10 (+0.25%)
At close · Sep 30
Return incl. dividend (before tax)
Market Cap
$2.61B
Shares
63.34M
Volume · Sep 30
540.21K
Avg daily vol (3M)
477.5K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| David Morris | Executive Vice President and Chief Financial Officer | $996,704 |
| Kendall Forbes | Executive Vice President, Sales & Operations | $994,734 |
| Fred Burke | President and Chief Executive Officer | $845,842 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Fred Burke | President and Chief Executive Officer | $766,103 |
| David Morris | Executive Vice President and Chief Financial Officer | $684,317 |
| Kendall Forbes | Executive Vice President, Sales & Operations | $681,050 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Fred Burke | President and Chief Executive Officer | $673,737 |
| David Morris | Executive Vice President and Chief Financial Officer | $587,324 |
| Kendall Forbes | Executive Vice President, Sales & Operations | $583,625 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Will Mudd | Senior Vice President and Chief Financial Officer | Appointed | 2026-06-22 |
| David Morris | Executive Vice President, Chief Operating Officer | Appointed | 2026-06-22 |
| Kendall Forbes | Executive Vice President of Sales & Operations | Retired | 2026-06-22 |
| Thomas Salentine, Jr. | Director (Bindley Capital Nominee) | Appointed | 2024-09-30 |
| Mary Sue Patchett | Director | Appointed | 2024-09-30 |
| Randall Lewis | Director | Appointed | 2024-09-30 |
| Steve Cosler | Director | Appointed | 2024-09-30 |
| John Ackerman | Director (Cardinal Stockholders Nominee) | Appointed | 2024-09-30 |
| William Bindley | Director (Bindley Capital Nominee) | Appointed | 2024-09-30 |